GENEREX BIOTECHNOLOGY CORP
GNBT
GNBT was delisted on the 20th of October, 2010.
2 hedge funds and large institutions have $2.04K invested in GENEREX BIOTECHNOLOGY CORP in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
31% more capital invested
Capital invested by funds: $1.56K → $2.04K (+$489)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| $2.04K | – | – | – |
|
GNBT Hedge Fund Activity: Q1 2014 in Review
2 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in GENEREX BIOTECHNOLOGY CORP (GNBT) for Q1 2014, worth a combined $2.04K — up 31% from $1.56K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of GNBT and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
- 2 institutional investors held GENEREX BIOTECHNOLOGY CORP (GNBT) as of Q1 2014, down from 3 in Q4 2013.
- Funds reported $2.04K of GENEREX BIOTECHNOLOGY CORP stock for Q1 2014, up 31% quarter-over-quarter.
- 0 funds opened new GENEREX BIOTECHNOLOGY CORP positions in Q1 2014 and 1 closed out, a net change of -1 holder.
Based on aggregated 13F filings for Q1 2014.